6th Research Congress of the EAPC reflects research in palliative care

The global interest for research in palliative care is increasing rapidly and The 6th Research Congress of the EAPC reflects this with a record number of abstracts and attendees --  more than 660 abstracts from 39 different countries will be presented to over 1200 international researchers and clinicians. Research to improve the care of patients with short life expectancy is a priority for governments in many countries. Large international collaborative research initiatives are beginning to bear fruit and a number of cutting edge studies will be presented in Glasgow. Highlights of the conference programme include:

·        Effect of genetics in cancer patients on their response to pain-killers like morphine

·        New strategies to avoid inappropriate transfers of terminally ill nursing home residents to hospitals at the end of life.

·        Mental clouding is prevalent in advanced disease but is an underestimated clinical problem. Helping clinicians to better understand its causes and management will improve the lives of patients and their carers.

·        Breathlessness is another common problem in advanced disease and associated with poor quality of life and shorter survival. Breathless patients need more attention, improved assessment and consequently better treatment.

The EAPC Research Network and the newly established European Palliative Care Research Centre will also be at the congress, presenting future research projects and an upcoming international PhD in palliative care.

http://www.eapcnet.org/research2010/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Antibiotic activity altered by interaction with nanoplastics, new research shows